Newsroom

Our mission is to push the boundaries of medicine with pioneering research and transformative therapies. We are committed to impacting patients globally with a team of experts.

Aug 2

JY BioMedical Collaborates with 3D Global Biotech and HeXun Biosciences to Explore New Applications for Drug-Eluting Stents

Date: October 2, 2024 According to a market research report, approximately 19.05 million deaths worldwide were attributed to...

Jul 5

Correction: Exclusive Technology Licensing Agreement Signed between HeXun Biosciences and JY BioMedical.

Date: July 5, 2024 Company Name: HeXun Biosciences Co., Ltd. Subject: Signing of an Exclusive Technology Licensing Agreement between...

Jul 1

HeXun Biosciences partners with JY BioMedical to sign a technology licensing agreement with a total value of 6 million USD

Date: July 1, 2024 HeXun Biosciences (6986), a company listed on the Emerging Stock Market, has recently reached a new milestone in its...